Squarepoint Ops LLC

Position in JANX — Janux Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in JANX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,395,600

+$3,000,463 QoQ

Shares Held

604,000

+54.5% QoQ

Ownership

0.990%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. JANX ranks #32 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,395,600	604,000	+54.5%	Shares	Defined	2026-05-15
2025-12-31	$5,395,137	390,952	+490.9%	Shares	Defined	2026-02-13
2025-09-30	$1,616,974	66,161	-65.1%	Shares	Defined	2025-11-14
2025-06-30	$4,379,043	189,569	+230.0%	Shares	Defined	2025-08-27
2025-03-31	$1,551,096	57,448	+39.5%	Shares	Defined	2025-08-27
2024-12-31	$2,204,563	41,176	+155.1%	Shares	Defined	2025-02-14
2024-09-30	$733,331	16,142	-50.9%	Shares	Defined	2024-11-14
2024-06-30	$1,376,589	32,862	-23.8%	Shares	Defined	2024-08-14
2024-03-31	$1,624,635	43,151	-29.5%	Shares	Defined	2024-05-15
2023-12-31	$656,332	61,168	+474.5%	Shares	Defined	2024-02-14
2023-09-30	$107,321	10,647	-61.7%	Shares	Defined	2023-11-14
2023-06-30	$329,748	27,780	+111.0%	Shares	Defined	2023-08-14
2023-03-31	$159,320	13,167	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.